Patients can also reach out online via chat, contact form, or Price Simulator.
High-risk patient factors include active gastrointestinal symptoms (odds ratio 7.66, 95% confidence interval 3.4217.17), early treatment phase (less than 4 weeks), higher medication doses, pre-existing diabetic gastroparesis, obesity (BMI greater than 30), and gastroesophageal reflux disease [31]
Jensterle, M., Pir, B., Goriar, K., Dolan, V
This supplement contains key ingredients of Ubiquinol Acetate (50 mg), L-Carnitine L-Tartrate (1000 mg), Astaxanthin (8 mg), Lycopene (2.5 mg) and Zinc (10 mg)
SAGE Publishing, Jan
Why Muscle Aches May Occur During GLP-1 Therapy GLP-1 medications work by slowing gastric emptying and signaling fullness in the brain, which reduces appetite and food intake dramatically in the first weeks